PAK4 pathway as a potential therapeutic target in pancreatic cancer

Future Oncol. 2018 Mar;14(7):579-582. doi: 10.2217/fon-2017-0458. Epub 2018 Mar 6.

Authors

Kiruthikah Thillai^{1

2}, Debashis Sarker^{1

2}, Claire Wells¹

Affiliations

¹ Cancer Studies, King's College London, London, SE1 9RT, UK.
² Department of Medical Oncology, Guy's & St Thomas' NHS Trust, London, SE1 9RT, UK.

PMID: 29508632
DOI: 10.2217/fon-2017-0458

No abstract available

Keywords: PAK4; p21 activated kinase; pancreatic cancer.

Publication types

Editorial
Review

MeSH terms

Biomarkers, Tumor / genetics*
Humans
Molecular Targeted Therapy*
Pancreatic Neoplasms / drug therapy
Pancreatic Neoplasms / genetics*
Pancreatic Neoplasms / pathology
p21-Activated Kinases / genetics*

Substances

Biomarkers, Tumor
PAK4 protein, human
p21-Activated Kinases